Share Capital

Share Capital is a Shenzhen-based venture firm investing in the modernization of healthcare delivery and B2B medical supply chain logistics, with broader exposure to digital health and tech-enabled care services at Series A and Series B. The firm’s positioning suggests interest in companies that improve how products and services move through the Chinese healthcare system, including procurement platforms, clinic operations software, and pharmacy or distribution networks. Shenzhen’s hardware ecosystem and proximity to the broader Pearl River Delta healthcare market underpin the firm’s deal flow. Limited public information about named partners, specific portfolio companies, and recent fund vintages is available in English-language sources.

Check sizes range from 1 million to 5 million dollars at Series A and Series B, sized to support commercial team expansion, geographic rollout, and operational scaling for B2B healthcare platforms. Geography centers on China with Shenzhen as the base, and the firm’s reach extends across the Pearl River Delta healthcare and pharmacy corridor. Companies focused outside the Chinese healthcare delivery ecosystem will not align with the thesis.

The approach suits founders building B2B platforms that serve hospitals, clinics, pharmacies, or medical distributors in China, where local supply chain fluency and procurement relationships are key advantages. Founders building therapeutic platforms or consumer-facing health applications without a clear B2B operational angle should look elsewhere. Initial conversations should focus on the company’s customer traction within target healthcare buyer segments, evidence of unit economics improving with scale, and the specific operational support Share Capital offers beyond capital, particularly around customer introductions and downstream financing.